phase i dose-escalation study of the bet inhibitor incb057643 in r/r myelofibrosis
Published 1 year ago • 176 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
2:18
update on phase i/ii study of glofitamab monotherapy in r/r mcl
-
1:24
phase i study of cd123 nk cell engager sar443579 in r/r aml, b-all or hr-mds
-
5:28
form 4 (chapter 4.6.2)
-
7:42
phase ii trial of bomedemstat for advanced myelofibrosis
-
2:46
challenges in selecting patients with mf for sct & using ai to determine the optimal timing for sct
-
2:12
monitoring disease in high-risk mm: euroflow with mass spectrometry
-
2:47
molecular background studies to aid diagnosis and treatment of mds
-
1:45
evaluating ipss-r and ipss-m in patients with hr-mds enrolled in stimulus-mds1 and stimulus-mds2
-
3:57
validation of the ipss-m risk stratification system in mds
-
11:01
relating retinal oxygen metabolism, thickness and visual function in experimental ischemia/
-
4:02
mass spectrometry analysis in peptidomic research with richard kay
-
12:17
updated iv and sc results from a phase i dose escalation study of forimtamig with rrmm patients
-
2:01
ptr-tof-ms, sampling system & tailored data analysis: bioprocess monitoring l protocol preview
-
2:01
ms analysis of mhc class i- and ii peptides : immunopeptidomics | protocol preview
-
0:45
science : expansion microscopy
-
3:52
imeta | mbpd: a multiple bacterial pathogen detection pipeline for one health practices
-
2:34
what are the criteria for high-risk progression?
-
8:09
the immune system: specialized cells and their functions (i out of ii) #bme210